PR Newswire Clinical TrialsOriginal article
Anixa Biosciences to Present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026
ConferencePositive
AI Analysis
Summary
Anixa Biosciences will present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026, highlighting its clinical progress and partnerships with Cleveland Clinic and Moffitt Cancer Center.
Importance:3/10
Sentiment:
0.30
conferencepresentationcancerclinical progresscollaboration
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 3, 2026 12:00 PM